| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $17.5M | — | +46.6% |
| R&D Expense | $6.1M | — | +10.2% |
| SG&A Expense | $5.8M | — | -1.0% |
| Operating Income | -$4.2M | — | +39.1% |
| Pre-tax Income | -$4.0M | — | +6.7% |
| Income Tax | $0 | — | — |
| Net Income | -$4.1M | — | +7.2% |
| EPS (Basic) | -$0.13 | — | +7.1% |
| EPS (Diluted) | -$0.13 | — | +7.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.1M | -22.9% | — |
| Current Assets | $32.0M | -4.9% | — |
| Total Assets | $63.9M | -8.8% | — |
| Current Liabilities | $7.8M | -27.4% | — |
| Total Liabilities | $11.1M | -23.7% | — |
| Stockholders' Equity | $16.5M | -9.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.3M | — | +36.8% |
| Investing Cash Flow | $2.5M | — | +216.6% |
| Financing Cash Flow | $1.2M | — | +306.7% |